The Patent Finder

Methods for Increasing Intracellular Activity of HSP70

Zevra Denmark A/S

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/DK2011/050444, filed Nov 22, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,662,375Methods for Increasing Intracellular Activity of HSP70
In force
 · High confidence
Zevra Denmark A/SIn force
High confidence
US 10,532,085Methods for Increasing Intracellular Activity of HSP70
In force
 · Medium confidence
Zevra Denmark A/SIn force
Medium confidence
Application 17/855,002Methods for Increasing Intracellular Activity of HSP70
Abandoned
Abandoned Dec 4, 2025
Zevra Denmark A/SAbandonedAbandoned Dec 4, 2025
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Zevra Denmark A/S.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited